Novo Nordisk
NVO
#20
Rank
ยฃ379.31 B
Marketcap
ยฃ83.48
Share price
2.37%
Change (1 day)
0.98%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Total assets

Total assets on the balance sheet as of September 2024 : ยฃ47.30 Billion

According to Novo Nordisk's latest financial reports the company's total assets are ยฃ47.30 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Novo Nordisk - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31ยฃ36.55 B27.3%
2022-12-31ยฃ28.71 B30.9%
2021-12-31ยฃ21.93 B24.83%
2020-12-31ยฃ17.57 B22.37%
2019-12-31ยฃ14.36 B7.42%
2018-12-31ยฃ13.36 B9.51%
2017-12-31ยฃ12.20 B9.08%
2016-12-31ยฃ11.19 B23.29%
2015-12-31ยฃ9.07 B12.29%
2014-12-31ยฃ8.08 B2.4%
2013-12-31ยฃ7.89 B9.58%
2012-12-31ยฃ7.20 B-0.65%
2011-12-31ยฃ7.25 B2.15%
2010-12-31ยฃ7.09 B8.93%
2009-12-31ยฃ6.51 B0.27%
2008-12-31ยฃ6.49 B38.04%
2007-12-31ยฃ4.70 B16.37%
2006-12-31ยฃ4.04 B5.18%
2005-12-31ยฃ3.84 B7.62%
2004-12-31ยฃ3.57 B9.62%
2003-12-31ยฃ3.26 B15.62%
2002-12-31ยฃ2.82 B-1.34%
2001-12-31ยฃ2.85 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
ยฃ174.39 B 268.63%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ60.07 B 26.99%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ74.43 B 57.33%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ110.52 B 133.62%๐Ÿ‡ซ๐Ÿ‡ท France